Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by JULKUNEN, H.
Right arrow Articles by FRIMAN, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by JULKUNEN, H.
Right arrow Articles by FRIMAN, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1991 British Society for Rheumatology

case-report

MALIGNANT HYPERTENSION AND ANTIPHOSPHOLIPID ANTIBODIES AS PRESENTING FEATURES OF SLE IN A YOUNG WOMAN USING ORAL CONTRACEPTIVES

H. JULKUNEN*,, R. KAAJA{dagger}, T. JOUHIKAINEN{ddagger}, A.-M. TEPPO* and C. FRIMAN*

*Fourth Department of Medicine, Helsinki University Central Hospital Helsinki, Finland
{dagger}Department of Obstetrics and Gynaecology, Helsinki University Central Hospital Helsinki, Finland
{ddagger}Finnish Red Cross Blood Transfusion Service Helsinki, Finland

Correspondence to: Correspondence to Dr H. Julkunen, Fourth Department of Medicine, Helsinki University Central Hospital, Unioninkatu 38, SF-00170, Helsinki 17, Finland

A 24-year-old woman developed malignant hypertension while on oral contraceptives (OCs). She was found to have incomplete systemic lupus erythematosus (SLE) with DNA antibodies and high levels of antiphospholipid antibodies (APLA). She later developed SLE and has had three miscarriages and a cerebellar infarction.

KEY WORDS: Lupus erythematosus, Ethinyloestradiol, Risks


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 LupusHome page
M Petri and J. Buyon
Editorial: Oral contraceptives in systemic lupus erythematosus: the case for (and against)
Lupus, August 1, 2008; 17(8): 708 - 710.
[PDF]

Home page
 LupusHome page
M Petri
Exogenous estrogen in systemic lupus erythematosus: oral contraceptives and hormone replacement therapy
Lupus, March 1, 2001; 10(3): 222 - 226.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.